Comments
Loading...

Universal Health Services Analyst Ratings

UHSNYSE
Logo brought to you by Benzinga Data
$171.68
-2.32-1.33%
At close: -
$171.68
0.000.00%
After Hours: Apr 25, 4:00 PM EDT
Q1 2025 earnings tomorrow on Mon Apr 28th after the market close
Conference call scheduled in 3 days at 9:00 AM Click to view the webcast
Consensus Rating1
Buy
Highest Price Target1
$267.00
Lowest Price Target1
$142.00
Consensus Price Target1
$204.37

Universal Health Services Analyst Ratings and Price Targets | NYSE:UHS | Benzinga

Universal Health Services Inc has a consensus price target of $204.37 based on the ratings of 30 analysts. The high is $267 issued by UBS on August 14, 2024. The low is $142 issued by Barclays on September 21, 2023. The 3 most-recent analyst ratings were released by Baird, Guggenheim, and Morgan Stanley on April 15, 2025, April 9, 2025, and March 26, 2025, respectively. With an average price target of $210.67 between Baird, Guggenheim, and Morgan Stanley, there's an implied 22.71% upside for Universal Health Services Inc from these most-recent analyst ratings.

Analyst Trends and Forecast
1
Dec 24
1
2
Feb
1
1
Mar
1
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
2.6
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Baird
Guggenheim
Morgan Stanley
Wells Fargo
Stephens & Co.

1calculated from analyst ratings

Analyst Ratings for Universal Health Services

Buy NowGet Alert
04/15/2025Buy Now30.48%Baird
Michael Ha50%
$274 → $224DowngradeOutperform → NeutralGet Alert
04/09/2025Buy Now21.16%Guggenheim
Jason Cassorla48%
→ $208Initiates → BuyGet Alert
03/26/2025Buy Now16.5%Morgan Stanley
Craig Hettenbach59%
→ $200Initiates → Equal-WeightGet Alert
03/10/2025Buy Now31.06%Wells Fargo
Stephen Baxter55%
$230 → $225MaintainsOverweightGet Alert
02/28/2025Buy Now29.89%Stephens & Co.
Scott Fidel 41%
$210 → $223MaintainsEqual-WeightGet Alert
02/27/2025Buy Now22.32%Stephens & Co.
Raj Kumar 49%
$210 → $210ReiteratesEqual-Weight → Equal-WeightGet Alert
02/27/2025Buy Now45.04%Barclays
Andrew Mok54%
$271 → $249MaintainsOverweightGet Alert
12/17/2024Buy Now31.64%JP Morgan
Benjamin Rossi10%
→ $226Assumes → NeutralGet Alert
11/26/2024Buy Now46.2%TD Cowen
Ryan Langston23%
$275 → $251MaintainsBuyGet Alert
11/25/2024Buy Now33.97%Wells Fargo
Stephen Baxter55%
$285 → $230MaintainsOverweightGet Alert
11/06/2024Buy Now66.01%Wells Fargo
Stephen Baxter55%
$275 → $285MaintainsOverweightGet Alert
10/28/2024Buy Now60.18%TD Cowen
Ryan Langston23%
$283 → $275MaintainsBuyGet Alert
10/28/2024Buy Now22.9%RBC Capital
Frank Morgan46%
$222 → $211MaintainsSector PerformGet Alert
10/25/2024Buy Now57.85%Barclays
Andrew Mok54%
$256 → $271MaintainsOverweightGet Alert
10/25/2024Buy Now27.56%Cantor Fitzgerald
Sarah James50%
$219 → $219ReiteratesNeutral → NeutralGet Alert
10/22/2024Buy Now60.18%Wells Fargo
Stephen Baxter55%
$255 → $275MaintainsOverweightGet Alert
10/16/2024Buy Now64.84%TD Cowen
Ryan Langston23%
$220 → $283UpgradeHold → BuyGet Alert
10/11/2024Buy Now—Keybanc
Matthew Gillmor63%
—Initiates → Sector WeightGet Alert
10/04/2024Buy Now27.56%Cantor Fitzgerald
Sarah James50%
$219 → $219ReiteratesNeutral → NeutralGet Alert
10/01/2024Buy Now27.56%Cantor Fitzgerald
Sarah James50%
$219 → $219ReiteratesNeutral → NeutralGet Alert
09/09/2024Buy Now29.31%RBC Capital
Ben Hendrix58%
$189 → $222MaintainsSector PerformGet Alert
09/04/2024Buy Now59.6%Baird
Michael Ha50%
$236 → $274MaintainsOutperformGet Alert
08/20/2024Buy Now27.56%Cantor Fitzgerald
Sarah James50%
$219 → $219ReiteratesNeutral → NeutralGet Alert
08/19/2024Buy Now27.56%Cantor Fitzgerald
Sarah James50%
$219 → $219ReiteratesNeutral → NeutralGet Alert
08/14/2024Buy Now55.52%UBS
A.J. Rice69%
$247 → $267MaintainsBuyGet Alert
07/30/2024Buy Now33.39%Goldman Sachs
Jamie Perse60%
$200 → $229MaintainsBuyGet Alert
07/30/2024Buy Now48.53%Wells Fargo
Stephen Baxter55%
$200 → $255MaintainsOverweightGet Alert
07/26/2024Buy Now28.15%TD Cowen
Gary Taylor60%
$183 → $220MaintainsHoldGet Alert
07/26/2024Buy Now27.56%Cantor Fitzgerald
Sarah James50%
$162 → $219UpgradeUnderweight → NeutralGet Alert
07/26/2024Buy Now49.11%Barclays
Andrew Mok54%
$198 → $256UpgradeEqual-Weight → OverweightGet Alert
07/25/2024Buy Now16.5%Stephens & Co.
Scott Fidel69%
$200 → $200ReiteratesEqual-Weight → Equal-WeightGet Alert
07/25/2024Buy Now-5.64%Cantor Fitzgerald
Sarah James50%
$162 → $162ReiteratesUnderweight → UnderweightGet Alert
07/10/2024Buy Now15.33%Barclays
Andrew Mok54%
$189 → $198MaintainsEqual-WeightGet Alert
07/10/2024Buy Now-5.64%Cantor Fitzgerald
Sarah James50%
$162 → $162ReiteratesUnderweight → UnderweightGet Alert
07/09/2024Buy Now-5.64%Cantor Fitzgerald
Sarah James50%
$162 → $162ReiteratesUnderweight → UnderweightGet Alert
07/02/2024Buy Now-5.64%Cantor Fitzgerald
Sarah James50%
$162 → $162ReiteratesUnderweight → UnderweightGet Alert
06/26/2024Buy Now37.47%Baird
Michael Ha50%
$198 → $236UpgradeNeutral → OutperformGet Alert
05/30/2024Buy Now8.34%JP Morgan
Lisa Gill59%
$182 → $186MaintainsNeutralGet Alert
05/30/2024Buy Now15.33%Baird
Michael Ha50%
→ $198Initiates → NeutralGet Alert
05/20/2024Buy Now31.64%UBS
A.J. Rice69%
$189 → $226UpgradeNeutral → BuyGet Alert
05/07/2024Buy Now10.09%RBC Capital
Ben Hendrix58%
$183 → $189MaintainsSector PerformGet Alert
04/30/2024Buy Now6.59%TD Cowen
Gary Taylor60%
$181 → $183MaintainsHoldGet Alert
04/26/2024Buy Now10.09%Barclays
Andrew Mok54%
$181 → $189MaintainsEqual-WeightGet Alert
04/25/2024Buy Now7.76%Stephens & Co.
Scott Fidel69%
$185 → $185ReiteratesEqual-Weight → Equal-WeightGet Alert
04/12/2024Buy Now18.24%Deutsche Bank
Pito Chickering67%
$208 → $203MaintainsBuyGet Alert
04/10/2024Buy Now-9.13%Cantor Fitzgerald
Sarah James50%
$156 → $156ReiteratesUnderweight → UnderweightGet Alert
03/28/2024Buy Now16.5%Wells Fargo
Stephen Baxter55%
$195 → $200MaintainsOverweightGet Alert
03/13/2024Buy Now6.01%JP Morgan
Calvin Sternick47%
$144 → $182MaintainsNeutralGet Alert
03/12/2024Buy Now6.59%RBC Capital
Ben Hendrix58%
$161 → $183MaintainsSector PerformGet Alert
03/06/2024Buy Now16.5%Mizuho
Ann Hynes85%
$175 → $200MaintainsBuyGet Alert
03/06/2024Buy Now5.43%Barclays
Andrew Mok54%
→ $181Initiates → Equal-WeightGet Alert
03/05/2024Buy Now-9.13%Cantor Fitzgerald
Sarah James50%
$156 → $156ReiteratesUnderweight → UnderweightGet Alert
03/04/2024Buy Now10.09%Goldman Sachs
Jamie Perse60%
$170 → $189MaintainsBuyGet Alert
03/01/2024Buy Now5.43%TD Cowen
Gary Taylor60%
$140 → $181MaintainsMarket PerformGet Alert
02/29/2024Buy Now-9.13%Cantor Fitzgerald
Sarah James50%
$148 → $156MaintainsUnderweightGet Alert
02/29/2024Buy Now12.42%Citigroup
Jason Cassorla48%
$170 → $193MaintainsBuyGet Alert
02/29/2024Buy Now3.1%UBS
Andrew Mok54%
$152 → $177MaintainsNeutralGet Alert
01/02/2024Buy Now3.1%Wells Fargo
Stephen Baxter55%
→ $177UpgradeEqual-Weight → OverweightGet Alert
12/11/2023Buy Now—Goldman Sachs
Jamie Perse60%
—UpgradeSell → BuyGet Alert
11/17/2023Buy Now-16.12%JP Morgan
Calvin Sternick47%
$152 → $144MaintainsNeutralGet Alert
10/20/2023Buy Now-19.04%Wells Fargo
Stephen Baxter55%
$153 → $139MaintainsEqual-WeightGet Alert
09/21/2023Buy Now-17.29%Barclays
Steven Valiquette58%
$142 → $142MaintainsEqual-WeightGet Alert
09/14/2023Buy Now-13.79%Cantor Fitzgerald
Sarah James50%
→ $148ReiteratesUnderweight → UnderweightGet Alert
07/27/2023Buy Now6.59%B of A Securities
Kevin Fischbeck68%
→ $183MaintainsBuyGet Alert
07/27/2023Buy Now-10.88%Wells Fargo
Stephen Baxter55%
→ $153MaintainsEqual-WeightGet Alert
07/27/2023Buy Now-1.56%Credit Suisse
Jonathan Yon52%
$163 → $169MaintainsOutperformGet Alert
07/26/2023Buy Now-9.72%Stephens & Co.
Scott Fidel69%
→ $155ReiteratesEqual-Weight → Equal-WeightGet Alert
07/11/2023Buy Now-0.98%Mizuho
Ann Hynes85%
$150 → $170MaintainsBuyGet Alert
06/02/2023Buy Now-5.06%B of A Securities
Kevin Fischbeck68%
→ $163AssumesNeutral → BuyGet Alert
05/26/2023Buy Now—SVB Securities
Whit Mayo66%
—UpgradeMarket Perform → OutperformGet Alert
05/16/2023Buy Now-19.04%Goldman Sachs
Jamie Perse60%
$124 → $139MaintainsSellGet Alert
05/16/2023Buy Now-12.63%Mizuho
Ann Hynes85%
$140 → $150MaintainsBuyGet Alert
05/08/2023Buy Now-10.3%TD Cowen
Gary Taylor60%
$138 → $154MaintainsMarket PerformGet Alert
04/27/2023Buy Now-3.89%Citigroup
Jason Cassorla48%
$150 → $165MaintainsBuyGet Alert
04/27/2023Buy Now-15.54%Stephens & Co.
Scott Fidel69%
$140 → $145MaintainsEqual-WeightGet Alert
04/27/2023Buy Now-9.72%Deutsche Bank
Pito Chickering67%
$145 → $155MaintainsBuyGet Alert
04/27/2023Buy Now-11.46%RBC Capital
Ben Hendrix58%
$130 → $152MaintainsSector PerformGet Alert
04/27/2023Buy Now-5.06%Credit Suisse
Jonathan Yon52%
$153 → $163MaintainsOutperformGet Alert
04/25/2023Buy Now-17.29%Barclays
Steve Valiquette54%
$132 → $142UpgradeUnderweight → Equal-WeightGet Alert
04/21/2023Buy Now-16.71%Cantor Fitzgerald
Sarah James50%
→ $143Initiates → UnderweightGet Alert
04/19/2023Buy Now-9.72%UBS
Andrew Mok54%
$167 → $155MaintainsNeutralGet Alert
04/19/2023Buy Now-22.53%JP Morgan
Calvin Sternick47%
→ $133Initiates → NeutralGet Alert
03/06/2023Buy Now-15.54%Deutsche Bank
Pito Chickering67%
$168 → $145MaintainsBuyGet Alert
03/06/2023Buy Now-18.45%Mizuho
Ann Hynes85%
$144 → $140MaintainsBuyGet Alert
03/06/2023Buy Now-19.62%Wells Fargo
Stephen Baxter55%
$154 → $138MaintainsEqual-WeightGet Alert
03/03/2023Buy Now-10.88%Credit Suisse
Jonathan Yon52%
$157 → $153MaintainsOutperformGet Alert
03/01/2023Buy Now-24.28%RBC Capital
Ben Hendrix58%
$114 → $130MaintainsSector PerformGet Alert
03/01/2023Buy Now-18.45%Stephens & Co.
Scott Fidel69%
$155 → $140MaintainsEqual-WeightGet Alert
03/01/2023Buy Now—Wolfe Research
Justin Lake33%
—DowngradeOutperform → Peer PerformGet Alert
02/28/2023Buy Now-6.8%B of A Securities
Kevin Fischbeck68%
→ $160MaintainsNeutralGet Alert
02/28/2023Buy Now-9.72%Stephens & Co.
Scott Fidel69%
→ $155Reiterates → Equal-WeightGet Alert
02/25/2023Buy Now-6.8%Deutsche Bank
Pito Chickering67%
$160 → $160MaintainsBuyGet Alert
01/24/2023Buy Now-2.73%UBS
Andrew Mok54%
$113 → $167UpgradeSell → NeutralGet Alert
01/09/2023Buy Now-23.11%Barclays
Steve Valiquette54%
$115 → $132MaintainsUnderweightGet Alert
01/03/2023Buy Now-10.3%Wells Fargo
Stephen Baxter55%
→ $154UpgradeUnderweight → Equal-WeightGet Alert
12/16/2022Buy Now-15.54%B of A Securities
Kevin Fischbeck68%
$120 → $145UpgradeUnderperform → NeutralGet Alert
12/14/2022Buy Now-16.12%Mizuho
Ann Hynes85%
$126 → $144MaintainsBuyGet Alert
11/25/2022Buy Now-8.55%Credit Suisse
Jonathan Yong65%
$129 → $157MaintainsOutperformGet Alert
11/14/2022Buy Now-34.18%UBS
Andrew Mok54%
$105 → $113MaintainsSellGet Alert
11/02/2022Buy Now-26.61%Mizuho
Ann Hynes85%
$121 → $126MaintainsBuyGet Alert

FAQ

Q

What is the target price for Universal Health Services (UHS) stock?

A

The latest price target for Universal Health Services (NYSE:UHS) was reported by Baird on April 15, 2025. The analyst firm set a price target for $224.00 expecting UHS to rise to within 12 months (a possible 30.48% upside). 42 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Universal Health Services (UHS)?

A

The latest analyst rating for Universal Health Services (NYSE:UHS) was provided by Baird, and Universal Health Services downgraded their neutral rating.

Q

When was the last upgrade for Universal Health Services (UHS)?

A

The last upgrade for Universal Health Services Inc happened on October 16, 2024 when TD Cowen raised their price target to $283. TD Cowen previously had a hold for Universal Health Services Inc.

Q

When was the last downgrade for Universal Health Services (UHS)?

A

The last downgrade for Universal Health Services Inc happened on April 15, 2025 when Baird changed their price target from $274 to $224 for Universal Health Services Inc.

Q

When is the next analyst rating going to be posted or updated for Universal Health Services (UHS)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Universal Health Services, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Universal Health Services was filed on April 15, 2025 so you should expect the next rating to be made available sometime around April 15, 2026.

Q

Is the Analyst Rating Universal Health Services (UHS) correct?

A

While ratings are subjective and will change, the latest Universal Health Services (UHS) rating was a downgraded with a price target of $274.00 to $224.00. The current price Universal Health Services (UHS) is trading at is $171.68, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch